Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
Clinical trial NCT00203047 · TERMINATED
Trial details
- NCT number
- NCT00203047
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2009-05-01
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.